Literature DB >> 12475923

Patents and public health. European institutions are challenging Myriad Genetics's patent monopoly on the brca1 gene.

Aude Lecrubier.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12475923      PMCID： PMC1308311          DOI： 10.1093/embo-reports/kvf251

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  2 in total

1.  The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.

Authors:  Berthold Rutz; Siobhán Yeats
Journal:  EMBO Rep       Date:  2004-02       Impact factor: 8.807

2.  Myriad Genetics: In the eye of the policy storm.

Authors:  E Richard Gold; Julia Carbone
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.